Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Renalytix plc quarterly Debt-to-equity history and growth rate from 2022 to 2024.
Renalytix plc Debt-to-equity for the quarter ending March 31, 2024 was -617 %, a 669% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q1 2024
-617
-725
-669%
Mar 31, 2024
Q4 2023
548
+462
+532%
Dec 31, 2023
Q3 2023
272
+221
+438%
Sep 30, 2023
Q2 2023
165
Jun 30, 2023
Q1 2023
108
Mar 31, 2023
Q4 2022
86.8
Dec 31, 2022
Q3 2022
50.5
Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.